A Novel Peer Mentoring Support System for Persons with Parkinson’s Disease
Objective: Research indicates that peer mentoring approaches can be effective in providing support as well as increasing the well-being of people with various disabilities or…eHealth Technologies for People with Parkinson’s: Acceptance & Implications
Objective: To investigate the impact of eHealth on Parkinson's care, focusing on technology acceptance and examining ethical, legal, social, and medical aspects of wearables. Background:…Common and specific immediate effects in brain oscillations and motor symptoms of tDCS and tACS in Parkinson’s disease: A randomized controlled trial
Objective: We conducted the first randomized controlled trial (RCT) to compare the modulation of Parkinson's disease (PD) patients by tDCS and tACS. Background: PD entails…Characterisation of the Pattern of Daily Motor Fluctuations in Patients with Parkinson’s Disease and Early Motor Fluctuations: Findings from the Korean ADOPTION Study
Objective: To characterise the pattern of daily motor fluctuations in Korean patients with Parkinson’s disease (PD) and early motor fluctuations. Background: Patients with PD may…A matching-adjusted indirect comparison of efficacy and safety for safinamide versus rasagiline as adjunctive treatment to levodopa in Chinese patients with Parkinson’s disease
Objective: To compare efficacy and safety of safinamide and rasagiline as adjunctive treatment to levodopa in Chinese patients with Parkinson’s disease (PD) by matching-adjusted indirect…Motor Phenotype Changes over time in Parkinson’s Disease. A 5-year Follow-up Study
Objective: The objectives of this study are to describe the prevalence of different motor phenotypes (MP) in a cohort of Parkinson’s Disease (PD) patients, to…Safety and tolerability of opicapone in Parkinson’s Disease: from early-stage (EPSILON study) to late-stage (BIPARK studies)
Objective: To compare the safety and tolerability of once-daily opicapone (OPC) 50mg as add-on to stable levodopa/dopa decarboxylase inhibitor (L-DOPA/DDCI) therapy in patients from early…Five-Year Changes in MDS-UPDRS-III after Light Treatment (Photobiomodulation)
Objective: To determine the effectiveness of photobiomodulation (light therapy) on MDS-UPDRS-III scores over a five-year period Background: As a progressive neurodegenerative disease, worsening of motor…Slow-SPEED-NL: study protocol for a remote trial of exercise for Parkinson’s disease prevention
Objective: To determine the feasibility and preliminary efficacy of a remote exercise intervention in prodromal Parkinson’s disease (PD). Background: Disease-slowing interventions have been ineffective in…Exidavnemab offers opportunities as a potential disease modifying therapy in several synucleinopathies
Objective: Immunotherapy against α-synuclein is a promising novel treatment strategy for Parkinson's disease and related α-synucleinopathies. We have developed exidavnemab (BAN0805), a monoclonal antibody with…
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 338
- Next Page »